EpistemisSynthesis and Comparative Tables
An analytical summary of key variables for advanced clinical decision making in neuropsychiatry.
File
Hepatic Metabolism Profile (CYP450) and Risk of Interactions
| Drug | Primary Target of Metabolism | Enzymatic Inhibitory / Inducing Effect | Relevant Clinical Consequence |
|---|---|---|---|
| Fluoxetine | CYP2D6, CYP2C19 | Potent CYP2D6 inhibitor | Dramatically increases levels of tricyclic antidepressants, tamoxifen ineffective. |
| Venlafaxine | CYP2D6, CYP3A4 | None clinically significant | Low risk of pharmacokinetic interaction; susceptible to CYP2D6 inhibitors. |
| Clozapine | CYP1A2, CYP3A4 | None | Levels extremely altered by changes in tobacco consumption (CYP1A2 inducer). |
| Lithium | Null (Renal) | None | Renal excretion dependent on proximal sodium reabsorption. It does not undergo metabolism. |
| Valproic Acid | Conjugation, UGT | Selective inhibitor of CYP2C9 and UGT | It doubles the half-life of lamotrigine, increasing the risk of lethal skin rash. |
| Methylphenidate | CES1 (Hydrolysis) | None | Rapid hydrolytic clearance, free of interactions mediated by the cytochrome P450 system. |
Principles of Gradual Withdrawal and Clinical Safety
As a general rule in neuropsychopharmacology, abrupt discontinuation of long-term therapies is associated with high rates of relapse or disabling discontinuation syndromes. A progressive percentage reduction of 10% to 25% weekly of the previous therapeutic dose is recommended to allow the physiological readaptation of receptors at a central level, especially in drugs with a short half-life such as venlafaxine or diazepam.
The precise management of psychotropic drugs requires understanding that there are no universal answers: analytical dosage and cellular molecular knowledge are the only real tools to guarantee efficacy and patient safety.
Epistemis is educational review material. It is not a medical device, does not diagnose or prescribe treatment, and does not replace formal medical training, current clinical guidelines, or professional clinical judgment.
- System
- Neurology and Psychiatry
- Cluster
- Comparative analysis